- Home
- ARTW vs CING Comparison
ARTW vs CING Comparison
Compare ARTW & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- CING
- Stock Information
- Founded
- ARTW 1956
- CING 2012
- Country
- ARTW United States
- CING United States
- Employees
- ARTW N/A
- CING N/A
- Industry
- ARTW Industrial Machinery/Components
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- CING Health Care
- Exchange
- ARTW Nasdaq
- CING Nasdaq
- Market Cap
- ARTW 23.5M
- CING 26.7M
- IPO Year
- ARTW N/A
- CING 2021
- Fundamental
- Price
- ARTW $3.15
- CING $3.77
- Analyst Decision
- ARTW
- CING Strong Buy
- Analyst Count
- ARTW 0
- CING 4
- Target Price
- ARTW N/A
- CING $31.00
- AVG Volume (30 Days)
- ARTW 75.0K
- CING 155.8K
- Earning Date
- ARTW 10-03-2025
- CING 11-06-2025
- Dividend Yield
- ARTW N/A
- CING N/A
- EPS Growth
- ARTW N/A
- CING N/A
- EPS
- ARTW 0.44
- CING N/A
- Revenue
- ARTW $23,523,353.00
- CING N/A
- Revenue This Year
- ARTW N/A
- CING N/A
- Revenue Next Year
- ARTW N/A
- CING N/A
- P/E Ratio
- ARTW $9.24
- CING N/A
- Revenue Growth
- ARTW N/A
- CING N/A
- 52 Week Low
- ARTW $1.43
- CING $3.02
- 52 Week High
- ARTW $4.71
- CING $7.00
- Technical
- Relative Strength Index (RSI)
- ARTW 47.43
- CING 41.45
- Support Level
- ARTW $2.96
- CING $3.61
- Resistance Level
- ARTW $3.43
- CING $4.43
- Average True Range (ATR)
- ARTW 0.32
- CING 0.27
- MACD
- ARTW -0.06
- CING -0.01
- Stochastic Oscillator
- ARTW 26.25
- CING 23.64
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.